• Tue, May 10, 2022

Paul Knight Maintained (BLFS) at Buy with Decreased Target to $30 on, May 10th, 2022

Paul Knight of Keybanc, Maintained "BioLife Solutions, Inc." (BLFS) at Buy with Decreased Target from $60 to $30 on, May 10th, 2022.

Paul has made no other calls on BLFS in the last 4 months.



There is 1 other peer that has a rating on BLFS. Out of the 1 peers that are also analyzing BLFS, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul


  • Suraj Kalia of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $28 on, Monday, April 25th, 2022

Like: 👍